Opportunistic fungal infections: Filamentous fungi and cryptococcosis

Geriatrics

Volumn 52, Issue 10, 1997, Pages 40-49

  Kauffman, Carol A ^a,b   Hedderwick, Sara ^c  

^a Veterans Affairs Medical Center

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

AGED; CRYPTOCOCCOSIS; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FUNGAL MENINGITIS; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; LUNG ASPERGILLOSIS; MUCORMYCOSIS; MYCOSIS; OPPORTUNISTIC INFECTION; REVIEW;

AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CRYPTOCOCCOSIS; FLUCONAZOLE; HUMANS; MIDDLE AGED; MUCORMYCOSIS; OPPORTUNISTIC INFECTIONS;

EID: 0031447306     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Banerjee SN, Emori TG, Culver DH, et al, and the National Nosocomial Infections Surveillence System. Secular trends in nosocomial primary blood-stream infections in the United States, 1980-1989. Am J Med 1991; 91(3B):86S-89S.
2. Komshian SV, Uwaydah AKJ, Sobel JD, Crane LR. Fungemia caused by Candida species and Torolopsis glabrata in the hospitalized patient: Frequency, characteristics and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11:379-90.
3. Harvey RL, Myers JP. Nosocomial fungemia in a large community teaching hospital. Arch Intern Med 1987; 147:2117-20.
4. Wetle T. Age as a risk factor for inadequate treatment. JAMA 1987; 258:516.
5. Weinblatt ME, Cobly JS, Fox DA, et al. Efficacy of low dose methotrexate in rheumatoid arthritis. N Engl J Med 1985; 312:818-22.
6. Roenigk HH, Auerbach R, Maibach HI, Weinstein GD. Methotrexate in psoriasis: Revised guidelines. J Am Acad Dermatol 1988; 19:145-56.
7. Wenzel RP, Pfaller MA. Candida species: Emerging hospital bloodstream pathogens. Infect Cont Hosp Epidemiol 1991; 12:523-4.
8. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39:1-8.
9. Rogers TJ, Balish E. Immunity to Candida albicans. Microbiol Rev 1980; 44:660-82.
10. Reef SE, Mayer KH. Opportunistic candidal infections in patients infected with human immunodeficiency virus: Prevention issues and priorities. Clin Infect Dis 1995; 21(1):S99-S102.
11. Horn R,Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 7:646-55.
12. Narhi TO, Ainamo A, Meurman JH. Salivary yeasts, saliva, and oral mucosa in the elderly. J Dent Res 1993; 72:1009-14.
13. Budtz-Jorgensen E. Oral mucosal lesions associated with the wearing of removeable dentures. J Oral Pathol 1981; 10:65-80.
14. Hofmann H, Brautigam M, Weidinger G, Zaun H, and the LAGOS II study group. Treatment of toenail onychomycosis. Arch Dermatol 1995; 131:919-22.
15. Sobel JD. Candida vaginitis. Infect Dis Clin Pract 1994; 3:334-9.
16. Stenchever MA. Management of vaginitis in the older woman. Geriatr Med Today 1987; 6:15-20.
17. Kauffman CA, Bradley SF, Vine AK. Candida endophthalmitis associated with intraocular lens implantation: Efficacy of fluconazole therapy. Mycoses 1993; 36:13-7.
18. Fisher JF, Newman CL, Sobel JD. Yeast in the urine: Solutions for a budding problem. Clin Infect Dis 1995; 20:183-9.
19. Jacobs LG, Skidmore EA, Freeman K, Lipschultz D, Fox N. Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clin Infect Dis 1996; 22:30-5.
20. Leu H, Huang C. Clearance of funguria with short-course antifungal regimens: A prospective, randomized, controlled study. Clin Infect Dis 1995; 20:1152-7.
21. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994; 331:1325-30.
22. Rex JH, Bennett JE, Sugar AM, et al. Intravascular catheter exchange and duration of candidemia. Clin Infect Dis 1995; 21:994-6.